Prelude Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
FAM
AC
Prelude Capital Management's CLB Position: Q4 2020 in Review
Prelude Capital Management sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 4,422 shares — an estimated $67K sold.
Prelude Capital Management first reported a position in CLB in Q3 2013 and held it in 12 quarters. The position peaked at $1.48M in Q1 2018. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.
- Prelude Capital Management reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
- Prelude Capital Management sold 4,422 Core Laboratories shares in Q4 2020, an estimated $67K.
- Prelude Capital Management first reported a position in Core Laboratories in Q3 2013 and held it in 12 quarters.
- Prelude Capital Management's Core Laboratories position peaked at $1.48M in Q1 2018.
- 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.
Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.